These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25747927)

  • 21. Implementation research: Issues and prospects.
    Flynn PM; Brown BS
    Addict Behav; 2011 Jun; 36(6):566-569. PubMed ID: 21236584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New systems of care for substance use disorders: treatment, finance, and technology under health care reform.
    Pating DR; Miller MM; Goplerud E; Martin J; Ziedonis DM
    Psychiatr Clin North Am; 2012 Jun; 35(2):327-56. PubMed ID: 22640759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Language-use disorder: comment on DSM-V's proposed 'addiction and related disorders' and Charles O'Brien's 'Addiction and dependence in DSM-V'.
    Courtwright DT
    Addiction; 2011 May; 106(5):878-9; discussion 895-7. PubMed ID: 21477234
    [No Abstract]   [Full Text] [Related]  

  • 24. Partnerships in drug abuse prevention services research: perspectives from the National Institute on Drug Abuse.
    Robertson EB; Sims BE; Reider EE
    Adm Policy Ment Health; 2012 Jul; 39(4):327-30. PubMed ID: 22203328
    [No Abstract]   [Full Text] [Related]  

  • 25. The national institute on drug abuse diversity scholars network: success for a diverse addiction science workforce.
    Avila AH; Weixelbaum JH; Goggans KR; Compton WM
    Neuropsychopharmacology; 2023 Dec; 48(13):1963-1967. PubMed ID: 37726356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 'anatomy' of research funding of mental illness and addictive disorders.
    Pincus HA; Fine T
    Arch Gen Psychiatry; 1992 Jul; 49(7):573-9. PubMed ID: 1627049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A transdiagnostic dimensional approach towards a neuropsychological assessment for addiction: an international Delphi consensus study.
    Yücel M; Oldenhof E; Ahmed SH; Belin D; Billieux J; Bowden-Jones H; Carter A; Chamberlain SR; Clark L; Connor J; Daglish M; Dom G; Dannon P; Duka T; Fernandez-Serrano MJ; Field M; Franken I; Goldstein RZ; Gonzalez R; Goudriaan AE; Grant JE; Gullo MJ; Hester R; Hodgins DC; Le Foll B; Lee RSC; Lingford-Hughes A; Lorenzetti V; Moeller SJ; Munafò MR; Odlaug B; Potenza MN; Segrave R; Sjoerds Z; Solowij N; van den Brink W; van Holst RJ; Voon V; Wiers R; Fontenelle LF; Verdejo-Garcia A
    Addiction; 2019 Jun; 114(6):1095-1109. PubMed ID: 30133930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
    Bart GB; Saxon A; Fiellin DA; McNeely J; Muench JP; Shanahan CW; Huntley K; Gore-Langton RE
    Addict Sci Clin Pract; 2020 Jan; 15(1):4. PubMed ID: 31948487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Addiction research centres and the nurturing of creativity. University of Michigan Addiction Research Center (UMARC): development, evolution, and direction.
    Zucker RA
    Addiction; 2010 Jun; 105(6):966-73. PubMed ID: 20331547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NIDA Boosts Research and Development of Medical Devices for Substance use Disorder via the NIH Blueprint MedTech Initiative.
    Kostov Y; Angelone L; Gutowski S; Koustova E
    Subst Use Misuse; 2023; 58(5):735-738. PubMed ID: 36866964
    [No Abstract]   [Full Text] [Related]  

  • 31. Use of multiple tobacco products in a national sample of persons enrolled in addiction treatment.
    Guydish J; Tajima B; Pramod S; Le T; Gubner NR; Campbell B; Roman P
    Drug Alcohol Depend; 2016 Sep; 166():93-9. PubMed ID: 27449271
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The NIDA clinical trials network: evolving, expanding, and addressing the opioid epidemic.
    Tai B; Dobbins R; Blackeney Q; Liu D; Moran L
    Addict Sci Clin Pract; 2021 May; 16(1):28. PubMed ID: 33964973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers and facilitators to implementing addiction medicine fellowships: a qualitative study with fellows, medical students, residents and preceptors.
    Klimas J; Small W; Ahamad K; Cullen W; Mead A; Rieb L; Wood E; McNeil R
    Addict Sci Clin Pract; 2017 Sep; 12(1):21. PubMed ID: 28927448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Meta-analyses of seven of the National Institute on Drug Abuse's principles of drug addiction treatment.
    Pearson FS; Prendergast ML; Podus D; Vazan P; Greenwell L; Hamilton Z
    J Subst Abuse Treat; 2012 Jul; 43(1):1-11. PubMed ID: 22119178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addiction research centres and the nurturing of creativity
department of addictive behaviour and addiction medicine, central institute of Mental Health, Mannheim, University of Heidelberg.
    Mann K
    Addiction; 2010 Dec; 105(12):2057-61. PubMed ID: 20528807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Globalization of Cooperative Groups.
    Valdivieso M; Corn BW; Dancey JE; Wickerham DL; Horvath LE; Perez EA; Urton A; Cronin WM; Field E; Lackey E; Blanke CD
    Semin Oncol; 2015 Oct; 42(5):693-712. PubMed ID: 26433551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Climbing above the forest and the trees: three future directions in addiction treatment research.
    Bricker JB
    Addiction; 2015 Mar; 110(3):414-5. PubMed ID: 25678288
    [No Abstract]   [Full Text] [Related]  

  • 39. How practice and science are balanced and blended in the NIDA Clinical Trials Network: the bidirectional process in the development of the STAGE-12 protocol as an example.
    Donovan DM; Daley DC; Brigham GS; Hodgkins CC; Perl HI; Floyd AS
    Am J Drug Alcohol Abuse; 2011 Sep; 37(5):408-16. PubMed ID: 21854284
    [TBL] [Abstract][Full Text] [Related]  

  • 40. National Institute on Drug Abuse: Dissemination of Scientific Knowledge to Improve Adolescent Health.
    Subramaniam GA; Nolan L; Huntley K; Corbin M; Crenshaw K; Mandell T; Linton J; Blackeney Q
    Psychiatr Clin North Am; 2023 Dec; 46(4):789-799. PubMed ID: 37879839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.